Federal Efforts to Measure Drugged Driving Are Losing Momentum as States Face a Data Gap

A major road-safety problem still lacks a national measurement system

The United States has long tracked alcohol’s role in fatal traffic crashes with relative clarity, but it still does not maintain an equivalent national picture for crashes involving drug impairment or combinations of drugs and alcohol. That gap is becoming more consequential as states loosen cannabis rules, the opioid crisis continues, and policymakers face pressure to understand how changing patterns of substance use affect driving risk.

A report on the issue points to a central problem: proving drug impairment is harder than proving alcohol impairment. Some substances can remain detectable long after the period of actual impairment has ended. That means blood tests alone do not cleanly answer the question that matters most in a crash investigation or courtroom: whether a driver was impaired at the time of the incident.

A Colorado crash shows both the stakes and the limits of current standards

The challenge is not abstract. The report recounts a September 2024 crash on U.S. Highway 6 in western Colorado in which a Jeep Grand Cherokee struck two state transportation workers on the shoulder, killing both workers and a passenger in the vehicle. According to the account, tests found the driver had oxycodone in his system and THC at six times Colorado’s presumed impairment threshold. He later pleaded guilty and is serving a 30-year prison sentence on three counts of vehicular homicide and other charges.

Yet even in a case with severe consequences, the science around thresholds remains contested. Colorado law allows a presumption of impairment when THC reaches 5 nanograms per liter of blood, but the report notes that this is a “permissible inference,” not the equivalent of the legal 0.08% blood alcohol limit used for alcohol. A defense attorney quoted in the piece said the threshold is not supported by published scientific studies.

That distinction highlights the policy problem facing regulators nationwide. States can set rules, but without a firmer scientific and federal framework, thresholds risk becoming blunt tools in an area where biology, timing, tolerance, and drug interactions all complicate interpretation.

Federal cuts are slowing already difficult work

The need for better measurement comes just as federal capacity is weakening. The report says efforts to expand and improve the tracking of drugged driving have been hurt by workforce cuts under President Donald Trump’s administration after his return to office in 2025, as well as by declining federal investment. Safety officials still describe impaired driving beyond alcohol as a top public-safety issue, but the system designed to study it appears to be under strain.

This matters because public policy is moving quickly in other directions. More than 40 states have legalized or decriminalized some form of cannabis or psychedelic drugs, while the national opioid emergency remains unresolved. Those changes create a larger need for defensible crash data, not a smaller one. Without it, lawmakers, police agencies, courts, and public-health officials are left making decisions with incomplete evidence.

The next phase of road safety may depend on better toxicology and better policy

Drugged driving is unlikely to yield to the same playbook used for alcohol. The science is more complex, the substances are more varied, and the relationship between detection and impairment is less direct. That means the federal government’s failure to build a more coherent tracking system is not a technical footnote. It is a structural weakness in how the country defines and responds to roadway risk.

The result is a policy mismatch: fatal crashes can involve drugs, prosecutors can bring serious charges, and states can adopt threshold rules, but the nation still lacks a consistent way to count, compare, and evaluate the problem at scale. As legal access to mind-altering substances expands, that gap will become harder to justify.

For now, the issue sits between criminal law, public health, and scientific uncertainty. The danger is clear enough. The measurement system is not.

This article is based on reporting by Medical Xpress. Read the original article.